These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10513666

  • 1. Pharmacokinetics of nelfinavir in an HIV patient with renal insufficiency.
    Izzedine H, Diquet B, Launay-Vacher V, Jouan M, Theou N, Deray G.
    AIDS; 1999 Oct 01; 13(14):1989. PubMed ID: 10513666
    [No Abstract] [Full Text] [Related]

  • 2. High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease.
    Maserati R, Villani P, Seminari E, Pan A, Lo Caputo S, Regazzi MB.
    AIDS; 1999 May 07; 13(7):870-1. PubMed ID: 10357395
    [No Abstract] [Full Text] [Related]

  • 3. Lack of removal of nelfinavir during a haemodialysis session in an HIV-1 infected patient with hepatic and renal insufficiency.
    Paci-Bonaventure S, Hafi A, Vincent I, Quertainmont Y, Goujard C, Charpentier B, Taburet AM.
    Nephrol Dial Transplant; 2001 Mar 07; 16(3):642-3. PubMed ID: 11239052
    [No Abstract] [Full Text] [Related]

  • 4. A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study).
    Podzamczer D, Ferrer E, Consiglio E, Gatell JM, Perez P, Perez JL, Luna E, González A, Pedrol E, Lozano L, Ocaña I, Llibre JM, Casiró A, Aranda M, Barrufet P, Martínez-Lacasa J, Miró JM, Badía X, Casado A, Lupo S, Cahn P, Maños M, Estela J.
    Antivir Ther; 2002 Jun 07; 7(2):81-90. PubMed ID: 12212928
    [Abstract] [Full Text] [Related]

  • 5. Triple nucleoside combination zidovudine/lamivudine/abacavir versus zidovudine/lamivudine/nelfinavir as first-line therapy in HIV-1-infected adults: a randomized trial.
    Matheron S, Descamps D, Boué F, Livrozet JM, Lafeuillade A, Aquilina C, Troisvallets D, Goetschel A, Brun-Vezinet F, Mamet JP, Thiaux C, CNA3007 Study Group.
    Antivir Ther; 2003 Apr 07; 8(2):163-71. PubMed ID: 12741629
    [Abstract] [Full Text] [Related]

  • 6. Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
    Ferrer E, Podzamczer D, Arnedo M, Fumero E, McKenna P, Rinehart A, Pérez JL, Barberá MJ, Pumarola T, Gatell JM, Gudiol F, Combine Study Team.
    J Infect Dis; 2003 Feb 15; 187(4):687-90. PubMed ID: 12599088
    [Abstract] [Full Text] [Related]

  • 7. Anti-HIV agents. Nelfinavir levels during pregnancy.
    TreatmentUpdate; 2004 Feb 15; 16(3):5-6. PubMed ID: 17216835
    [No Abstract] [Full Text] [Related]

  • 8. Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.
    Bennetto-Hood C, Bryson YJ, Stek A, King JR, Mirochnick M, Acosta EP.
    HIV Clin Trials; 2009 Feb 15; 10(1):41-7. PubMed ID: 19362995
    [Abstract] [Full Text] [Related]

  • 9. Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine.
    Atkinson B, Isaacson J, Knowles M, Mazabel E, Patick AK.
    J Infect Dis; 2000 Aug 15; 182(2):420-7. PubMed ID: 10915071
    [Abstract] [Full Text] [Related]

  • 10. Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing.
    Schuster T, Linde R, Wintergerst U, Funk MB, Kurowski M, Kreuz W, Hofmann D.
    AIDS; 2000 Jul 07; 14(10):1466-8. PubMed ID: 10930171
    [No Abstract] [Full Text] [Related]

  • 11. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
    Reiser M, Salzberger B, Stiepel A, Hoetelmans R, Diehl V, Fätkenheuer G.
    Eur J Med Res; 1999 Feb 25; 4(2):54-8. PubMed ID: 10066640
    [Abstract] [Full Text] [Related]

  • 12. Antiretroviral rounds. When success is a pain.
    Bartlett JG, del Rio C.
    AIDS Clin Care; 2001 Aug 25; 13(8):74-5. PubMed ID: 11547461
    [No Abstract] [Full Text] [Related]

  • 13. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.
    Hugen PW, Verweij-van Wissen CP, Burger DM, Wuis EW, Koopmans PP, Hekster YA.
    J Chromatogr B Biomed Sci Appl; 1999 Apr 30; 727(1-2):139-49. PubMed ID: 10360433
    [Abstract] [Full Text] [Related]

  • 14. Maintaining the nelfinavir trough concentration above 0.8 mg/L improves virologic response in HIV-1-infected children.
    Burger DM, Bergshoeff AS, De Groot R, Gibb D, Walker S, Tréluyer JM, Hoetelmans RM, PENTA 5 study group.
    J Pediatr; 2004 Sep 30; 145(3):403-5. PubMed ID: 15343199
    [Abstract] [Full Text] [Related]

  • 15. Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations.
    Gonzàlez de Requena D, Núñez M, de Mendoza C, Jiménez-Nàcher I, Soriano V.
    AIDS; 2003 Feb 14; 17(3):442-4. PubMed ID: 12556700
    [No Abstract] [Full Text] [Related]

  • 16. Anti-HIV effects of nelfinavir reported after ten months of combination therapy.
    AIDS Patient Care STDS; 1997 Aug 14; 11(4):289-90. PubMed ID: 11361848
    [No Abstract] [Full Text] [Related]

  • 17. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C, Bevilacqua S, Beguinot I, Dorvaux V, Schuhmacher H, May T, Canton P.
    Clin Infect Dis; 2001 May 15; 32(10):1494-5. PubMed ID: 11317252
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of nelfinavir and nevirapine in a patient with end-stage renal failure on continuous ambulatory peritoneal dialysis.
    Taylor S, Little J, Halifax K, Drake S, Back D.
    J Antimicrob Chemother; 2000 May 15; 45(5):716-7. PubMed ID: 10797104
    [No Abstract] [Full Text] [Related]

  • 19. The pharmacokinetics of nelfinavir in HIV-1-infected children.
    van Heeswijk RP, Scherpbier HJ, de Koning LA, Heymans HS, Lange JM, Beijnen JH, Hoetelmans RM.
    Ther Drug Monit; 2002 Aug 15; 24(4):487-91. PubMed ID: 12142631
    [Abstract] [Full Text] [Related]

  • 20. Simplifying drug regimens.
    HIV Hotline; 1998 Mar 15; 8(1):11. PubMed ID: 11365353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.